Article, Early Access, 2024

Clinical trial evaluation: the EDOSURE clinical trial program

FUTURE CARDIOLOGY, ISSN 1479-6678, 10.1080/14796678.2024.2354079

Contributors

Griffin, Michael (Corresponding author) [1] [2] [3] Lip, Gregory Y. H. [1] [2] [3] [4]

Affiliations

  1. [1] Liverpool Heart & Chest Hosp, Liverpool L14 3PE, England
    2. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  2. [2] Liverpool John Moores Univ, Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool L14 3PE, England
    3. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  3. [3] Liverpool John Moores Univ, Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool L14 3PE, England
    4. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  4. [4] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, DK-9260 Aalborg, Denmark
    5. [NORA names: AAU Aalborg University; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

atrial fibrillation, edoxaban, stroke, venous thromboembolism

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+